38761634|t|Gastrodin ameliorates synaptic impairment, mitochondrial dysfunction and oxidative stress in N2a/APP cells.
38761634|a|Alzheimer's disease is characterized by abnormal beta-amyloid and tau accumulation, mitochondrial dysfunction, oxidative stress, and synaptic dysfunction. Here, we aimed to assess the mechanisms and signalling pathways in the neuroprotective effect of gastrodin, a phenolic glycoside, on murine neuroblastoma N2a cells expressing human Swedish mutant APP (N2a/APP). We found that gastrodin increased the levels of presynaptic-SNAP, synaptophysin, and postsynaptic-PSD95 and reduced phospho-tau Ser396, APP and Abeta1-42 levels in N2a/APP cells. Gastrodin treatment reduced reactive oxygen species generation, lipid peroxidation, mitochondrial fragmentation and DNA oxidation; restored mitochondrial membrane potential and intracellular ATP production. Upregulated phospho-GSK-3beta and reduced phospho-ERK and phospho-JNK were involved in the protective effect of gastrodin. In conclusion, we demonstrated the neuroprotective effect of gastrodin in the N2a/APP cell line by ameliorating the impairment on synaptic and mitochondrial function, reducing tau phosphorylation, Abeta1-42 levels as well as reactive oxygen species generation. These results provide new mechanistic insights into the potential effect of gastrodin in the treatment of Alzheimer's disease.
38761634	0	9	Gastrodin	Chemical	MESH:C045345
38761634	22	41	synaptic impairment	Disease	MESH:D012183
38761634	43	68	mitochondrial dysfunction	Disease	MESH:D028361
38761634	93	97	N2a/	CellLine	CVCL:0470
38761634	97	100	APP	Gene	351
38761634	108	127	Alzheimer's disease	Disease	MESH:D000544
38761634	192	217	mitochondrial dysfunction	Disease	MESH:D028361
38761634	241	261	synaptic dysfunction	Disease	MESH:C536122
38761634	360	369	gastrodin	Chemical	MESH:C045345
38761634	373	391	phenolic glycoside	Chemical	-
38761634	396	402	murine	Species	10090
38761634	403	416	neuroblastoma	Disease	MESH:D009447
38761634	417	420	N2a	CellLine	CVCL:0470
38761634	438	443	human	Species	9606
38761634	459	462	APP	Gene	351
38761634	464	467	N2a	CellLine	CVCL:0470
38761634	468	471	APP	Gene	351
38761634	488	497	gastrodin	Chemical	MESH:C045345
38761634	540	553	synaptophysin	Gene	20977
38761634	572	577	PSD95	Gene	13385
38761634	610	613	APP	Gene	351
38761634	638	642	N2a/	CellLine	CVCL:0470
38761634	642	645	APP	Gene	351
38761634	653	662	Gastrodin	Chemical	MESH:C045345
38761634	681	704	reactive oxygen species	Chemical	MESH:D017382
38761634	717	722	lipid	Chemical	MESH:D008055
38761634	737	764	mitochondrial fragmentation	Disease	MESH:D012892
38761634	844	847	ATP	Chemical	MESH:D000255
38761634	880	889	GSK-3beta	Gene	56637
38761634	910	913	ERK	Gene	26413
38761634	926	929	JNK	Gene	26419
38761634	972	981	gastrodin	Chemical	MESH:C045345
38761634	1044	1053	gastrodin	Chemical	MESH:C045345
38761634	1061	1064	N2a	CellLine	CVCL:0470
38761634	1065	1068	APP	Gene	351
38761634	1208	1231	reactive oxygen species	Chemical	MESH:D017382
38761634	1320	1329	gastrodin	Chemical	MESH:C045345
38761634	1350	1369	Alzheimer's disease	Disease	MESH:D000544
38761634	Negative_Correlation	MESH:C045345	MESH:D009447
38761634	Negative_Correlation	MESH:C045345	351
38761634	Positive_Correlation	MESH:C045345	56637
38761634	Positive_Correlation	MESH:C045345	MESH:D000255
38761634	Negative_Correlation	MESH:C045345	MESH:D008055
38761634	Negative_Correlation	MESH:C045345	MESH:D012183
38761634	Negative_Correlation	MESH:C045345	MESH:D017382
38761634	Negative_Correlation	MESH:C045345	26413
38761634	Negative_Correlation	MESH:C045345	MESH:D012892
38761634	Negative_Correlation	MESH:C045345	26419
38761634	Positive_Correlation	MESH:C045345	20977
38761634	Negative_Correlation	MESH:C045345	MESH:D028361
38761634	Positive_Correlation	MESH:C045345	13385
38761634	Negative_Correlation	MESH:C045345	MESH:D000544

